https://stock.noler.com/us/stock/drug https://stock.noler.com/us/stock/drug/13f-holdings https://stock.noler.com/us/stock/drug/accounting-profit https://stock.noler.com/us/stock/drug/accruals-classified-as-current https://stock.noler.com/us/stock/drug/activist-13d-13g https://stock.noler.com/us/stock/drug/additions-to-rightofuse-assets https://stock.noler.com/us/stock/drug/adjusted-weighted-average-shares https://stock.noler.com/us/stock/drug/adjustments-for-decrease-increase-in-prepaid-expenses https://stock.noler.com/us/stock/drug/adjustments-for-decrease-increase-in-trade-and-other-receivables https://stock.noler.com/us/stock/drug/adjustments-for-depreciation-and-amortisation-expense https://stock.noler.com/us/stock/drug/adjustments-for-impairment-loss-recognised-in-profit-or-loss-goodwill https://stock.noler.com/us/stock/drug/adjustments-for-increase-decrease-in-trade-account-payable https://stock.noler.com/us/stock/drug/adjustments-for-share-based-payments https://stock.noler.com/us/stock/drug/adjustments-for-unrealised-foreign-exchange-losses-gains https://stock.noler.com/us/stock/drug/amended-reports-10-k https://stock.noler.com/us/stock/drug/analyst-ratings-buy https://stock.noler.com/us/stock/drug/analyst-ratings-hold https://stock.noler.com/us/stock/drug/analyst-ratings-no-rating https://stock.noler.com/us/stock/drug/analyst-ratings-sell https://stock.noler.com/us/stock/drug/applicable-tax-rate https://stock.noler.com/us/stock/drug/auditor https://stock.noler.com/us/stock/drug/basic-and-diluted-earnings-loss-per-share https://stock.noler.com/us/stock/drug/basic-earnings-loss-per-share https://stock.noler.com/us/stock/drug/business https://stock.noler.com/us/stock/drug/buybacks https://stock.noler.com/us/stock/drug/cash-and-cash-equivalents https://stock.noler.com/us/stock/drug/cash-flow-breakdown https://stock.noler.com/us/stock/drug/cash-flows-from-used-in-financing-activities https://stock.noler.com/us/stock/drug/cash-flows-from-used-in-operating-activities https://stock.noler.com/us/stock/drug/cash-outflow-for-leases https://stock.noler.com/us/stock/drug/clinical-trials https://stock.noler.com/us/stock/drug/company-guidance https://stock.noler.com/us/stock/drug/company-profile https://stock.noler.com/us/stock/drug/congressional-trades-stocks-including-adrs https://stock.noler.com/us/stock/drug/convertible-securities-retired https://stock.noler.com/us/stock/drug/cover-page-shares-outstanding https://stock.noler.com/us/stock/drug/current-assets https://stock.noler.com/us/stock/drug/current-lease-liabilities https://stock.noler.com/us/stock/drug/current-liabilities https://stock.noler.com/us/stock/drug/current-prepaid-expenses https://stock.noler.com/us/stock/drug/current-ratio https://stock.noler.com/us/stock/drug/current-tax-assets-current https://stock.noler.com/us/stock/drug/debt-equity-ratio https://stock.noler.com/us/stock/drug/deductible-temporary-differences-for-which-no-deferred-tax-asset-is-recognised https://stock.noler.com/us/stock/drug/depreciation-rightofuse-assets https://stock.noler.com/us/stock/drug/diluted-earnings-loss-per-share https://stock.noler.com/us/stock/drug/directors-remuneration-expense https://stock.noler.com/us/stock/drug/dividend https://stock.noler.com/us/stock/drug/dividend-safety https://stock.noler.com/us/stock/drug/ebitda https://stock.noler.com/us/stock/drug/ebitda-margin https://stock.noler.com/us/stock/drug/effect-of-exchange-rate-changes-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/drug/employee-count https://stock.noler.com/us/stock/drug/equity https://stock.noler.com/us/stock/drug/equity-and-liabilities https://stock.noler.com/us/stock/drug/executive-pay-pvp https://stock.noler.com/us/stock/drug/executive-salary-officers https://stock.noler.com/us/stock/drug/expense-breakdown https://stock.noler.com/us/stock/drug/expense-by-nature https://stock.noler.com/us/stock/drug/expense-from-share-based-payment-transactions-in-which-goods-or-services-received-did-not-qualify-for-recognition-as-assets https://stock.noler.com/us/stock/drug/expense-from-share-based-payment-transactions-with-employees https://stock.noler.com/us/stock/drug/form-144-stocks https://stock.noler.com/us/stock/drug/form-n-port-stocks https://stock.noler.com/us/stock/drug/gains-losses-on-exchange-differences-on-translation-recognised-in-profit-or-loss https://stock.noler.com/us/stock/drug/general-and-administrative-expense https://stock.noler.com/us/stock/drug/graph https://stock.noler.com/us/stock/drug/gross-margin https://stock.noler.com/us/stock/drug/impairment-loss-recognised-in-profit-or-loss-intangible-assets-and-goodwill https://stock.noler.com/us/stock/drug/included-in-etf https://stock.noler.com/us/stock/drug/income-tax-expense https://stock.noler.com/us/stock/drug/increase-decrease-in-cash-and-cash-equivalents https://stock.noler.com/us/stock/drug/increase-decrease-in-number-of-shares-outstanding https://stock.noler.com/us/stock/drug/increase-decrease-through-exercise-of-warrants-equity https://stock.noler.com/us/stock/drug/increase-decrease-through-net-exchange-differences-rightofuse-assets https://stock.noler.com/us/stock/drug/increase-decrease-through-share-based-payment-transactions https://stock.noler.com/us/stock/drug/insider-transactions https://stock.noler.com/us/stock/drug/intangible-assets-and-goodwill https://stock.noler.com/us/stock/drug/interest-expense-on-lease-liabilities https://stock.noler.com/us/stock/drug/iran-activity-notices-irannotice https://stock.noler.com/us/stock/drug/issued-capital https://stock.noler.com/us/stock/drug/key-management-personnel-compensation https://stock.noler.com/us/stock/drug/key-management-personnel-compensation-share-based-payment https://stock.noler.com/us/stock/drug/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/drug/lease-liabilities https://stock.noler.com/us/stock/drug/market-cap https://stock.noler.com/us/stock/drug/material-contracts https://stock.noler.com/us/stock/drug/net-fee-amt https://stock.noler.com/us/stock/drug/net-margin https://stock.noler.com/us/stock/drug/news https://stock.noler.com/us/stock/drug/noncurrent-lease-liabilities https://stock.noler.com/us/stock/drug/operating-margin https://stock.noler.com/us/stock/drug/options-activity https://stock.noler.com/us/stock/drug/other-current-receivables https://stock.noler.com/us/stock/drug/other-reserves https://stock.noler.com/us/stock/drug/outstanding-bonds https://stock.noler.com/us/stock/drug/patents-active https://stock.noler.com/us/stock/drug/payments-for-share-issue-costs https://stock.noler.com/us/stock/drug/payments-of-lease-liabilities-classified-as-financing-activities https://stock.noler.com/us/stock/drug/pb-ratio https://stock.noler.com/us/stock/drug/pe-ratio https://stock.noler.com/us/stock/drug/pre-tax-margin https://stock.noler.com/us/stock/drug/preferred-shares https://stock.noler.com/us/stock/drug/previous-etf-holding-it https://stock.noler.com/us/stock/drug/price-fcf-ratio https://stock.noler.com/us/stock/drug/proceeds-from-issue-of-ordinary-shares https://stock.noler.com/us/stock/drug/proceeds-from-issuing-other-equity-instruments https://stock.noler.com/us/stock/drug/proceeds-from-issuing-shares https://stock.noler.com/us/stock/drug/professional-fees-expense https://stock.noler.com/us/stock/drug/profit-breakdown https://stock.noler.com/us/stock/drug/profit-loss https://stock.noler.com/us/stock/drug/ps-ratio https://stock.noler.com/us/stock/drug/quick-ratio https://stock.noler.com/us/stock/drug/research-and-development https://stock.noler.com/us/stock/drug/retained-earnings https://stock.noler.com/us/stock/drug/return-on-tangible-equity https://stock.noler.com/us/stock/drug/revenue-breakdown https://stock.noler.com/us/stock/drug/revenue-from-interest https://stock.noler.com/us/stock/drug/rightofuse-assets https://stock.noler.com/us/stock/drug/roa https://stock.noler.com/us/stock/drug/roe https://stock.noler.com/us/stock/drug/roi https://stock.noler.com/us/stock/drug/sales-and-marketing-expense https://stock.noler.com/us/stock/drug/scorecard https://stock.noler.com/us/stock/drug/sec-comment-letters-upload https://stock.noler.com/us/stock/drug/sec-enforcement-actions https://stock.noler.com/us/stock/drug/sec-filings-10-q https://stock.noler.com/us/stock/drug/sec-filings-25-nse https://stock.noler.com/us/stock/drug/sec-filings-8-k https://stock.noler.com/us/stock/drug/sec-filings-px14a6g https://stock.noler.com/us/stock/drug/sec-filings-s-4 https://stock.noler.com/us/stock/drug/secondary-offerings https://stock.noler.com/us/stock/drug/share-issue-related-cost https://stock.noler.com/us/stock/drug/shares-outstanding https://stock.noler.com/us/stock/drug/short-sale-volume https://stock.noler.com/us/stock/drug/stock-issued https://stock.noler.com/us/stock/drug/stock-splits https://stock.noler.com/us/stock/drug/subsidiaries https://stock.noler.com/us/stock/drug/tax-expense-income-at-applicable-tax-rate https://stock.noler.com/us/stock/drug/total-assets https://stock.noler.com/us/stock/drug/total-liabilities https://stock.noler.com/us/stock/drug/trade-and-other-current-payables https://stock.noler.com/us/stock/drug/trade-and-other-current-payables-to-related-parties https://stock.noler.com/us/stock/drug/trade-and-other-current-payables-to-trade-suppliers https://stock.noler.com/us/stock/drug/ttl-fee-amt https://stock.noler.com/us/stock/drug/ttl-offering-amt https://stock.noler.com/us/stock/drug/ttl-offset-amt https://stock.noler.com/us/stock/drug/warrant-reserve https://stock.noler.com/us/stock/drug/weighted-average-shares